Pembrolizumab for Locally Advanced, Irresectable, Non-metastatic dMMR Colorectal Cancers

NCT05131919 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Pembrolizumab

Sponsor

The Netherlands Cancer Institute

Collaborators

[object Object]